Cargando…
Renin Angiotensin System and COVID-19 Infection
Purpose: The new coronavirus, called SARS-CoV-2, is responsible for the recent global pandemic COVID-19. The status of the global pandemic COVID-19 is currently underway, and the virus has caused about 1.11 million deaths. Several SARS-CoV-2 vaccines are in phase 3 clinical trials. Pending the avail...
Autores principales: | Ferrara, Francesco, Vitiello, Antonio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Tabriz University of Medical Sciences
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9012934/ https://www.ncbi.nlm.nih.gov/pubmed/35517880 http://dx.doi.org/10.34172/apb.2022.001 |
Ejemplares similares
-
Pharmacological agents modifying the renin angiotensin and natriuretic peptide systems in COVID-19 patients
por: Vitiello, Antonio, et al.
Publicado: (2021) -
The renin-angiotensin system and specifically angiotensin-converting enzyme 2 as a potential therapeutic target in SARS-CoV-2 infections
por: Ferrara, Francesco, et al.
Publicado: (2021) -
Correction to: The renin‑angiotensin system and specifically angiotensin‑converting enzyme 2 as a potential therapeutic target in SARS‑CoV‑2 infections
por: Ferrara, Francesco, et al.
Publicado: (2021) -
Drugs acting on the renin–angiotensin system and SARS-CoV-2
por: Vitiello, Antonio, et al.
Publicado: (2021) -
COVID-19 and the Renin-Angiotensin System
por: Malha, Line, et al.
Publicado: (2020)